Investor: Betting on Bio in 2026 Looks Like Robotics in 2023 — Cheap, Undervalued, Talent Influx
arian_ghashghai · x · 2026-10-07
Investor Arian Ghashghai (Earthling VC) closed his 7th bio deal of 2026 and says bio today mirrors robotics circa 2023: AI-driven step change in what's buildable, cheaper and faster paths to market, obvious impact but undervalued at pre-seed, and top-tier CS and bio talent founding companies.
Related event: Investor: Betting on Bio in 2026 Is Like Betting on Robotics in 2023(2 posts)→
More from Venture
- a16z maps consumer AI: winners in search, creative tools, productivity; gaps everywhere else — omooretweets · 2026-10-07
- Earthling VC doubles down on bio with 7th deal of 2026, likening it to robotics in 2023 — arian_ghashghai · 2026-10-07
- AI silicon demand at 110-120% of leading-edge wafer capacity, Bajarin argues all foundries win — BenBajarin · 2026-10-07
- Coinbase Institute paper: AI agents are the internet's second customer, and stablecoins fit micro-payments — kleffew94 · 2026-10-07
- ARIA's £50M Scaling Trust program reveals first 12 teams securing AI agent coordination — DavideCrapis · 2026-10-07
- AI chip testing is the new bottleneck: winstek approves NT$13.4B capex on NT$2.7B revenue — tengyanAI · 2026-10-07